Tiotropium bromide - Boehringer Ingelheim

Drug Profile

Tiotropium bromide - Boehringer Ingelheim

Alternative Names: BA-679-BR; HGP 1011; Spiriva; Spiriva HandiHaler; Spiriva Respimat; Tiotropium; Tiotropium bromide monohydrate; Tiotropium HFA BAI; Tiotropium hydrofluoroalkane breath actuated inhaler; Tiotropium Respimat®

Latest Information Update: 04 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim
  • Class Antiasthmatics; Antibronchitics; Epoxy compounds; Esters; Small molecules; Thiophenes; Tropanes
  • Mechanism of Action Muscarinic M1 receptor antagonists; Muscarinic M3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Asthma; Chronic obstructive pulmonary disease
  • Phase III Cystic fibrosis
  • Discontinued Lung cancer

Most Recent Events

  • 29 Aug 2018 Generic equivalent available in western Europe for Chronic obstructive pulmonary disease
  • 18 May 2018 Interim pharmacokinetics data from a phase III NinoTinA-asthma® trial in Asthma presented at the 114th International Conference of the American Thoracic Society (ATS-2018)
  • 18 May 2018 Pooled efficacy data from two phase III PrimoTinA-asthma® trials in asthma presented at the 114th International Conference of the American Thoracic Society (ATS-2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top